CD68 and neoplasm: In the control group, iNOS density in the tumor area was significantly lower compared to the BGS treatment group (control 33.6 ± 9.4; BGS 67.1 ± 8.8), and many of the CD68 cells were iNOS negative (Fig. 8D; white arrows).